tiprankstipranks
COSMO Pharmaceuticals N.V. (DE:C43)
FRANKFURT:C43
Germany Market
C43
COSMO Pharmaceuticals N.V.
RESEARCH TOOLSreports

COSMO Pharmaceuticals N.V. (C43) Ratios

4 Followers

COSMO Pharmaceuticals N.V. Ratios

DE:C43's free cash flow for Q2 2026 was €0.44. For the 2026 fiscal year, DE:C43's free cash flow was decreased by € and operating cash flow was €-0.19. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 10.66 7.18 4.19 3.98 1.57
Quick Ratio
 10.12 6.77 3.91 3.42 1.51
Cash Ratio
 1.25 2.19 0.92 1.96 0.95
Solvency Ratio
 0.06 0.07 1.03 0.07 0.10
Operating Cash Flow Ratio
 -0.81 -0.46 3.36 0.88 0.17
Short-Term Operating Cash Flow Coverage
 -27.58 -82.39 1.17K 165.75 0.19
Net Current Asset Value
€ 141.41M€ 59.77M€ 60.58M€ -22.72M€ 10.29M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 <0.01 0.23
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 <0.01 0.38
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 <0.01 0.28
Long-Term Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Financial Leverage Ratio
 1.23 1.27 1.30 1.31 1.66
Debt Service Coverage Ratio
 -2.71 -0.72 574.50 1.55 0.22
Interest Coverage Ratio
 -45.20 -57.54 1.30K 0.72 3.01
Debt to Market Cap
 <0.01 <0.01 <0.01 <0.01 0.17
Interest Debt Per Share
 0.27 0.28 0.14 0.64 11.14
Net Debt to EBITDA
 41.68 -21.88 -0.25 -2.46 -0.26
Profitability Margins
Gross Profit Margin
45.52%46.53%92.55%57.60%81.62%
EBIT Margin
-13.37%-10.00%57.51%6.62%32.94%
EBITDA Margin
-0.62%2.25%62.11%21.23%45.79%
Operating Profit Margin
-13.37%-10.00%55.81%6.62%27.48%
Pretax Profit Margin
-3.92%-0.88%57.49%1.65%23.97%
Net Profit Margin
-6.18%-3.46%49.94%-5.32%16.87%
Continuous Operations Profit Margin
-6.02%-3.35%49.92%-5.10%17.15%
Net Income Per EBT
157.48%393.03%86.87%-321.93%70.38%
EBT Per EBIT
29.35%8.81%103.01%24.93%87.23%
Return on Assets (ROA)
-0.91%-0.59%20.60%-0.89%2.27%
Return on Equity (ROE)
-1.21%-0.75%26.74%-1.17%3.77%
Return on Capital Employed (ROCE)
-2.05%-1.79%24.88%1.16%4.97%
Return on Invested Capital (ROIC)
-2.04%-1.78%21.57%-3.59%2.72%
Return on Tangible Assets
-1.82%-1.38%45.81%-2.83%4.67%
Earnings Yield
-0.64%-0.20%12.02%-0.56%1.70%
Efficiency Ratios
Receivables Turnover
 2.80 4.10 14.09 3.26 2.64
Payables Turnover
 3.94 4.95 2.18 4.48 2.47
Inventory Turnover
 4.15 5.38 1.47 2.77 1.63
Fixed Asset Turnover
 3.33 3.41 9.17 3.25 3.37
Asset Turnover
 0.15 0.17 0.41 0.17 0.13
Working Capital Turnover Ratio
 0.52 0.67 2.31 0.99 0.56
Cash Conversion Cycle
 125.84 83.26 106.94 162.18 214.12
Days of Sales Outstanding
 130.43 89.12 25.91 111.94 138.05
Days of Inventory Outstanding
 88.05 67.82 248.23 131.73 223.68
Days of Payables Outstanding
 92.64 73.68 167.20 81.49 147.62
Operating Cycle
 218.48 156.94 274.15 243.67 361.73
Cash Flow Ratios
Operating Cash Flow Per Share
 -1.18 -0.73 9.93 1.41 2.02
Free Cash Flow Per Share
 -1.40 -0.99 9.58 1.14 1.58
CapEx Per Share
 0.22 0.27 0.35 0.27 0.45
Free Cash Flow to Operating Cash Flow
 1.19 1.36 0.97 0.81 0.78
Dividend Paid and CapEx Coverage Ratio
 -0.42 -0.31 4.30 1.07 1.45
Capital Expenditure Coverage Ratio
 -5.38 -2.74 28.73 5.17 4.55
Operating Cash Flow Coverage Ratio
 -4.64 -2.73 73.79 12.35 0.19
Operating Cash Flow to Sales Ratio
 -0.20 -0.11 0.61 0.24 0.33
Free Cash Flow Yield
-2.39%-0.88%14.14%2.07%2.55%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -152.33 -491.19 8.32 -178.94 58.94
Price-to-Sales (P/S) Ratio
 9.69 17.21 4.15 9.51 9.94
Price-to-Book (P/B) Ratio
 1.74 3.74 2.22 2.09 2.22
Price-to-Free Cash Flow (P/FCF) Ratio
 -41.78 -113.83 7.07 48.19 39.17
Price-to-Operating Cash Flow Ratio
 -49.12 -155.31 6.82 38.86 30.55
Price-to-Earnings Growth (PEG) Ratio
 1.49 4.78 >-0.01 1.38 -3.17
Price-to-Fair Value
 1.74 3.74 2.22 2.09 2.22
Enterprise Value Multiple
 -1.52K 743.79 6.44 42.34 21.46
Enterprise Value
 968.29M 1.75B 1.07B 834.11M 1.00B
EV to EBITDA
 -1.52K 743.79 6.44 42.34 21.46
EV to Sales
 9.43 16.71 4.00 8.99 9.82
EV to Free Cash Flow
 -40.65 -110.58 6.80 45.55 38.70
EV to Operating Cash Flow
 -48.21 -150.87 6.57 36.73 30.19
Tangible Book Value Per Share
 13.30 8.72 9.12 3.07 4.44
Shareholders’ Equity Per Share
 33.27 30.18 30.46 26.21 27.82
Tax and Other Ratios
Effective Tax Rate
 -0.53 -2.80 0.13 4.09 0.28
Revenue Per Share
 6.03 6.57 16.31 5.76 6.22
Net Income Per Share
 -0.37 -0.23 8.14 -0.31 1.05
Tax Burden
 1.57 3.93 0.87 -3.22 0.70
Interest Burden
 0.29 0.09 1.00 0.25 0.73
Research & Development to Revenue
 0.30 0.31 <0.01 0.20 0.15
SG&A to Revenue
 0.28 0.26 0.03 0.06 0.03
Stock-Based Compensation to Revenue
 0.00 0.02 <0.01 0.04 0.02
Income Quality
 3.16 3.20 1.06 14.82 1.36
Currency in EUR